Several studies have revealed an inverse correlation between patient survival and serum IL-6 levels or mRNA expression in various types of tumors, including head and neck squamous cell carcinoma, esophageal cancer, gastric cancer, ovarian cancer and lung cancer 9, 11, 30-32. This evidence concerns the gene IL6 and ovarian carcinoma.